Go to content
UR Home

mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease

URN to cite this document:
urn:nbn:de:bvb:355-epub-513523
DOI to cite this document:
10.5283/epub.51352
Wege, Anja Kathrin ; Rom‐Jurek, Eva‐Maria ; Jank, Paul ; Denkert, Carsten ; Ugocsai, Peter ; Solbach, Christine ; Blohmer, Jens‐Uwe ; Sinn, Bruno ; Mackelenbergh, Marion ; Möbus, Volker ; Trumpp, Andreas ; Marangoni, Elisabetta ; Pfarr, Nicole ; Irlbeck, Christoph ; Warfsmann, Jens ; Polzer, Bernhard ; Weber, Florian ; Ortmann, Olaf ; Loibl, Sibylle ; Vladimirova, Valentina ; Brockhoff, Gero
[img]
Preview
License: Creative Commons Attribution Non-commercial No Derivatives 4.0
PDF - Published Version
Early View
(11MB)
Date of publication of this fulltext: 11 Jan 2022 07:17


Abstract

Estrogen receptor-positive breast cancer is a highly prevalent but heterogeneous disease among women. Advanced molecular stratification is required to enable individually most efficient treatments based on relevant prognostic and predictive biomarkers. First objective of our study was the hypothesis-driven discovery of biomarkers involved in tumor progression upon xenotransplantation of Luminal ...

plus


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de
0941 943 4239

Dissertations: dissertationen@ur.de
0941 943 3904

Research data: daten@ur.de
0941 943 4239

Contact persons